According to the FDA, some patients using Serevent (salmeteral), a popular asthma medication, might face life-threatening complications and possible death. FDA officials emphasize that problems from Serevent occurred rarely. The FDA and GlaxoSmithKline, the maker of Serevent, contend that the drug's benefits outweigh its risks.
Serevent, Advair, and Seretide asthma medications are under close scrutiny by the FDA. The active ingredient contained seems to be capable of actually causing asthma attacks in some circumstances - puzzling because it also protects against asthma attacks, or at least it should. Questions remain unanswered in a study conducted over seven years by the drug's sponsor, GlaxoSmithKline, in response to FDA's request. Clinical trials demonstrated an increased rate of asthma-related deaths, according to the FDA, by a factor ranging from three to eight times greater than patients receiving no medication.Patients currently using any of these asthma products are strongly cautioned not to stop using them without consulting their physician. Stopping use of this medication without replacing it with another asthma medication under the supervision of a physician could be fatal.
Patients may have experienced a near-fatal asthma attack or died from asthma while using any of the asthma medications Serevent, Advair, or Seretide, or other asthma products containing salmeterol xinafoate. Patients' asthma may have progressed and worsened rather than being controlled effectively. The risks may be greater for non-Caucasian patients.
Serevent, Advair Articles
Complications and Death linked to SereventSerevent, the inhaler medication for asthmatics, and Advair, the inhaler combining Serevent and Flovent, continue to be widely prescribed despite a 13-year history of complications. Serevent, Flovent and Advair, manufactured by GlaxoSmithKline, are a wildly successful line of inhaler drugs for the company, but Serevent has been the kiss of death for too many unfortunate users.
Serevent: Scientists Push for Recall, Advocates Claim Big Pharma Coverup
According to Cornell and Stanford University researchers, the asthma drugs Serevent, Advair and Foradil should be recalled due to health safety concerns. In light of these findings, consumer advocates are outraged that the drugs remain on the market, and question whether there has been a coverup by Big Pharma.
Every Breath You Take: Serevent Can Make Asthma Problem Worse
Serevent: No Cause to Breathe Any Easier
Advair Deadly for Asthmatics
Serevent Sufferer
